Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

[1]  D. Baker,et al.  Mortality trends for 23,505 Medicare patients hospitalized with heart failure in Northeast Ohio, 1991 to 1997. , 2003, American heart journal.

[2]  P. Austin,et al.  Care and Outcomes of Patients Newly Hospitalized for Heart Failure in the Community Treated by Cardiologists Compared With Other Specialists , 2003, Circulation.

[3]  H. Krum,et al.  Demographics and concomitant disorders in heart failure , 2003, The Lancet.

[4]  J. Tu,et al.  Prognosis and Determinants of Survival in Patients Newly Hospitalized for Heart Failure: A Population-Based Study , 2002 .

[5]  James B. Young.  Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial , 2002 .

[6]  R. Califf,et al.  Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. , 2002, JAMA.

[7]  H. Krumholz,et al.  Mortality associated with the quality of care of patients hospitalized with congestive heart failure. , 2002, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[8]  D. Grobbee,et al.  Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980 to 1999: the end of an epidemic? , 2002, Heart.

[9]  H. Krumholz,et al.  A Qualitative Study of Increasing β-Blocker Use After Myocardial Infarction: Why Do Some Hospitals Succeed? , 2001 .

[10]  H. Liedholm,et al.  Survival after initial hospitalisation for heart failure: a multilevel analysis of patients in Swedish acute care hospitals , 2001, Journal of epidemiology and community health.

[11]  J. McMurray,et al.  Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak? , 2001, European heart journal.

[12]  William T. Abraham,et al.  Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE) * ** , 2000 .

[13]  J. Cohn.  Experience with expedited reviews , 2000 .

[14]  J. O’Connell,et al.  The economic burden of heart failure , 2000, Clinical cardiology.

[15]  R F Anda,et al.  Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population. , 1999, Archives of internal medicine.

[16]  Y Wang,et al.  Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. , 1997, Archives of internal medicine.

[17]  G. Bonsel,et al.  Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. , 1994, American journal of public health.

[18]  J. McMurray,et al.  Trends in hospitalization for heart failure in Scotland 1980-1990. , 1993, European heart journal.

[19]  R. Cooper,et al.  Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence. , 1990, Archives of internal medicine.

[20]  Salim Yusuf,et al.  Studies of left ventricular dysfunction (SOLVD)--rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. , 1990, The American journal of cardiology.